Shukra Pharmaceuticals Ltd. - Research Center
524632 SHUKRAPHAR Group (XT) BSE data
Add to watchlist
| Results | |
| Statement |
Cash flow
|
| More |
Cash flow
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Profit before tax | 19.88 | 4.44 | 1.02 | 0.10 | 0.17 |
| Net cashflow-operating activity | -5.20 | 3.17 | 7.78 | 0.37 | 1.00 |
| Net cash used in investing activity | -1.20 | -4.43 | -1.53 | -1.81 | -3.11 |
| Netcash used in fin. activity | 12.41 | 4.94 | -6.68 | 1.72 | 1.99 |
| Net inc/dec in cash and equivlnt | 6.01 | 3.68 | -0.42 | 0.28 | -0.12 |
| Cash and equivalnt begin of year | 3.97 | 0.29 | 0.50 | 0.13 | 0.25 |
| Cash and equivalnt end of year | 9.98 | 3.97 | 0.09 | 0.41 | 0.13 |
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis